注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户？ 登录
🎉 尊享股票精析，五一轻松解锁财富密码 领取限时折扣
323.240
+2.780
+0.87%
类型:
基金
市场:
卢森堡
发行商:
AXA Funds Management S.A.
ISIN:
LU0266013803
资产类别:
股票
- 晨星评级:
- 总资产: 270.42M
AXA World Funds - Framlington Health F Capitalisat
323.240
+2.780
+0.87%
0P00007Y4O概述
本页面提供安盛环球基金 - 泛灵顿健康 FC USD的详细介绍，帮助您了解0P00007Y4O的高管、总资产、投资策略和联系方式等信息。
投资策略
寻求从一个积极管理的上市股票、股票相关证券及衍生工具投资组合，取得阁下以美元计价的投资的长期增长及应用esg方法。附属基金接受积极管理，参考摩根士丹利资本国际所有国家世界总回报净额指数（「基准」）仅作比较用途。投资经理对附属基金投资组合的组成成分拥有完全酌情权，并可对不包含在基准内的公司、国家或界别作出投资参与。附属基金投资组合及其表现可偏离基准的程度并无任何限制。附属基金投资于已发展及新兴市场的大型、中型及小型公司。
联络信息
地址
Paseo de la Castellana 93, 6a planta
Madrid,none 28046
Spain
Madrid,none 28046
Spain
电话
+34 91 406 72 18
传真
+34 91 406 72 01
高管
| 名称 | 标题 | 任期 | 至 |
|---|---|---|---|
| Gregg Bridger | - | 2023 | now |
| 背景介紹 | Gregg Bridger is a fund manager in the global equities team. Prior to joining FOUR, he was employed as a Product Specialist in the Fundamental equities team at Goldman Sachs Asset Management. Previously, Gregg was an assistant portfolio manager in the emerging markets equity team at Credit Suisse. Gregg holds a BA (Hons) in Economics from the University of Leicester and is a CFA Charterholder. | ||
| Stephen Kelly | Portfolio Manager | 2023 | now |
| 背景介紹 | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Stephen Kelly | Portfolio Manager | 2021 | 2023 |
| 背景介紹 | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Peter Hughes | Portfolio Manager | 2021 | 2023 |
| 背景介紹 | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Linden Thomson | - | 2015 | 2021 |
| Dani Saurymper | - | 2015 | 2021 |
| 背景介紹 | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
| Peter Hughes | Portfolio Manager | 2007 | 2021 |
| 背景介紹 | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Gemma Game | - | 2009 | 2015 |
| Deane Donnigan | clinical Specialist | 2007 | 2008 |
| 背景介紹 | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. | ||
在评论中添加图表
确认屏蔽
确定屏蔽%USER_NAME%？
如果屏蔽，您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人，因此必须等待48小时才能重新屏蔽。
举报该评论
您举报该评论的原因为：
该评论已被标注
谢谢您!
您的举报将会被发送到管理员进行审核